AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India has informed the stock exchange that its trading window is closed in line with SEBI's Prohibition of Insider Trading Regulations, 2015. The trading window is typically shut ahead of a board meeting to declare financial results, a major corporate action, or any other material price-sensitive information. During this period, directors, key managerial personnel, and other insiders are barred from trading in the company's shares. The exact duration and reason (such as upcoming quarterly results) are not specified in this short filing but are usually disclosed by the company separately.
This is a routine compliance filing and by itself does not affect shareholders. However, the window closure often signals that a material announcement — most commonly quarterly or annual financial results — is likely to be made soon, which investors should watch for.